Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6982)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 15, 2018 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yaprak O, Acar S, Ertugrul G, Dayangac M. Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation. World J Gastrointest Oncol 2018; 10(10): 336-343 [PMID: 30364796 DOI: 10.4251/wjgo.v10.i10.336] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i10/336.htm |
| Number | Citing Articles |
| 1 |
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and management. Liver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004
|
| 2 |
Seok-Hwan Kim, Deok-Bog Moon, Gil-Chun Park, Sung-Gyu Lee, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Young-In Yoon, Hwa-Jung Kim. Preoperative prediction score of hepatocellular carcinoma recurrence in living donor liver transplantation: Validation of SNAPP score developed at Asan Medical Center. American Journal of Transplantation 2021; 21(2): 604 doi: 10.1111/ajt.16227
|
| 3 |
Ender Anılır, Alihan Oral, Fatih Turker, Tolga Şahin, Feyza Sönmez Topçu, Yıldıray Yuzer, Yaman Tokat. Predictive Value of Preoperative 18 Fludeoxyglucose Positron Emission Tomography–Computed Tomography for Survival in Liver Transplantation Due to Hepatocellular Cancer. Transplantation Proceedings 2024; 56(1): 111 doi: 10.1016/j.transproceed.2023.12.007
|
| 4 |
Shengpan Jiang, Xiaoqing Gao, Yueli Tian, Jie Chen, Yichun Wang, Yaqun Jiang, Yong He. The potential of 18F-FDG PET/CT metabolic parameter-based nomogram in predicting the microvascular invasion of hepatocellular carcinoma before liver transplantation. Abdominal Radiology 2024; doi: 10.1007/s00261-023-04166-8
|
| 5 |
Sirish A. Kishore, Michael J. Drabkin, Constantinos T. Sofocleous. Fluorodeoxyglucose-PET for Ablation Treatment Planning, Intraprocedural Monitoring, and Response. PET Clinics 2019; 14(4): 427 doi: 10.1016/j.cpet.2019.06.006
|
| 6 |
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. Radiologic Clinics of North America 2021; 59(5): 737 doi: 10.1016/j.rcl.2021.06.001
|
| 7 |
Thomas Winkens, William Rudakoff, Falk Rauchfuss, Christina Malessa, Utz Settmacher, Martin Freesmeyer. FDG PET/CT to Detect Incidental Findings in Patients With Hepatocellular Carcinoma—Additional Benefit for Patients Considered for Liver Transplantation?. Clinical Nuclear Medicine 2021; 46(7): 532 doi: 10.1097/RLU.0000000000003576
|
| 8 |
Satoru Hagiwara, Naoshi Nishida, Masatoshi Kudo. Advances in Immunotherapy for Hepatocellular Carcinoma. Cancers 2023; 15(7): 2070 doi: 10.3390/cancers15072070
|
| 9 |
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations. Journal of Clinical and Experimental Hepatology 2020; 10(1): 43 doi: 10.1016/j.jceh.2019.09.007
|
| 10 |
Michele Finotti, Alessandro Vitale, Michael Volk, Umberto Cillo. A 2020 update on liver transplant for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2020; 14(10): 885 doi: 10.1080/17474124.2020.1791704
|
| 11 |
Edouard Reizine, Julia Chalaye, Sebastien Mule, Helene Regnault, Clara Perrin, Julien Calderaro, Alexis Laurent, Giuliana Amaddeo, Hicham Kobeiter, Vania Tacher, Emmanuel Itti, Alain Luciani. Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular Carcinoma. American Journal of Roentgenology 2022; 218(2): 359 doi: 10.2214/AJR.21.26485
|
| 12 |
Silvio Nadalin, Lara Genedy, Alfred Königsrainer. Ethical Challenges in Cancer Diagnosis and Therapy. Recent Results in Cancer Research 2021; 218: 135 doi: 10.1007/978-3-030-63749-1_10
|
| 13 |
Pierluigi Toniutto, Elisa Fumolo, Ezio Fornasiere, Davide Bitetto. Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review. Journal of Clinical Medicine 2021; 10(17): 3932 doi: 10.3390/jcm10173932
|
| 14 |
Filiz Çelebi, Aysegül Görmez, Ahmet Serkan Ilgun, Yaman Tokat, Numan Cem Balcı. The value of 18F-FDG PET/MRI in prediction of microvascular invasion in hepatocellular carcinoma. European Journal of Radiology 2022; 149: 110196 doi: 10.1016/j.ejrad.2022.110196
|
| 15 |
Masatoshi Kudo. Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma. Liver Cancer 2022; 11(5): 399 doi: 10.1159/000526163
|
| 16 |
Francesco Paolo Russo, Alberto Zanetto. Textbook of Liver Transplantation. 2022; : 389 doi: 10.1007/978-3-030-82930-8_22
|
| 17 |
Bedriye Koyuncu Sökmen, Nagihan Inan. 18 F-FDG PET/MRI of Primary Hepatic Malignancies: Differential Diagnosis
and Histologic Grading. Current Medical Imaging Formerly Current Medical Imaging Reviews 2023; 20 doi: 10.2174/1573405620666230508105758
|
| 18 |
Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, Kaoru Tsuchiya, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Naoshi Nishida, Chikara Ogawa, Tetsu Tomonari, Noriaki Nakamura, Hidekatsu Kuroda, Atsushi Takebe, Yoshifumi Takeyama, Masaaki Hidaka, Susumu Eguchi, Stephen L Chan, Masayuki Kurosaki, Namiki Izumi. Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study. Liver Cancer 2023; 12(4): 321 doi: 10.1159/000529574
|
| 19 |
Jae Hyun Yoon, Sung Kyu Choi. Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes. Journal of Liver Cancer 2023; 23(2): 300 doi: 10.17998/jlc.2023.08.27
|
| 20 |
Yi Wei, Zixing Huang, Hehan Tang, Liping Deng, Yuan Yuan, Jiaxing Li, Dongbo Wu, Xiaocheng Wei, Bin Song. IVIM improves preoperative assessment of microvascular invasion in HCC. European Radiology 2019; 29(10): 5403 doi: 10.1007/s00330-019-06088-w
|
| 21 |
Shohei Fukai, Hiromitsu Daisaki, Naoki Shimada, Mitsutomi Ishiyama, Takuro Umeda, Kosuke Yamashita, Noriaki Miyaji, Tomohiro Takiguchi, Hideyuki Kawakami, Takashi Terauchi. Evaluation of data-driven respiratory gating for subcentimeter lesions using digital PET/CT system and three-axis motion phantom. Biomedical Physics & Engineering Express 2023; 9(1): 015006 doi: 10.1088/2057-1976/aca90d
|
| 22 |
Omar Dzaye, Francois H. Cornelis, Henry S. Kunin, Constantinos T. Sofocleous. Advancements and Future Outlook of PET/CT-Guided Interventions. Techniques in Vascular and Interventional Radiology 2023; 26(3): 100916 doi: 10.1016/j.tvir.2023.100916
|
| 23 |
Filiz Çelebi, Kourosh Yaghouti, Emetullah Cindil, Gülen Bülbül Dogusoy, Yaman Tokat, Cem Balcı. The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms. Academic Radiology 2021; 28(2): 189 doi: 10.1016/j.acra.2020.01.026
|